The humans the algorithms can't reach
Patients don’t start, stay on, or return to therapy because they receive a notification at the right time.
Newsletters and Deep Dive digital magazine
Patients don’t start, stay on, or return to therapy because they receive a notification at the right time.
AstraZeneca will voluntarily take its anticoagulant reversal agent Andexxa off the market in the US amid reports of serious clotting side effects.
Lirio's Dr Amy Bucher discusses the risks of the declining trust in healthcare institutions from a behavioural science perspective.
Shares in DBV have shot up on phase 3 results that set up a US filing for its peanut allergy therapy. which could plug a looming hole in the market.
Overturning decades of advice, the CDC has said it no longer recommends that all US newborns receive a hepatitis B vaccine.
Editor's Picks
Newsletters and Deep Dive
digital magazine